Hepatitis B and Hepatitis C Virus Infections in Stem Cell Transplantation

References

• Scaglioni PP, Melegari M, Wands JR. Recent advances in the molecular biology of hepatitis B virus. In Viral Hepatitis, edit. BAILLIERE's Clinical Gastroenterology 1996; 207–225
   PubMed Web of Science ®Google Scholar
• Chisari FU, Filippi P, Buras J, et al. Structural and pathologi:cal effects of synthesis of HBV large envelope polypeptides in transgenic mice. PNAS USA 1987; 84: 6909–13
   PubMed Web of Science ®Google Scholar
• Gilles PN, Guenette DL, Ulevitch RJ. HBsAg retention sensitises the hepatocyte to injury by physiological concentrations of IFN. JAMA/Hepatology 1992; 16: 655–63
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Bacigalupo A, VanLint MT, et al. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1990; 6: 25–29
   PubMed Web of Science ®Google Scholar
• Reed E., Myerson D, Corey L, Meyers JD. Allogeneic Marrow Transplantation in patients positive for Hepatitis B Surface Antigen. Blood 1991; 77: 195–200
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Alberti A, de Bock R, et al. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group- Infectious Diseases Working Party. Bone Marrow Transplant 1994; 14: 833–837
   PubMed Web of Science ®Google Scholar
• Chen P, Liu J, Fan FS, et al. Liver disease after bone marrow transplantation- The Taiwan experience. Transplantation 1995; 59: 1139–1143
   PubMed Web of Science ®Google Scholar
• Lau GKK, Liang R, Chiu EKW, Lam SK. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 1997; 19: 795–799
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Testa M, Bonizzoni E, Ljungman P, Alberti A. The role of hepatitis C and hepatitis B virus infections as risk factors for severe liver complications following allogeneic bone marrow transplantation (BMT): a prospective study of the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group (ID-WP, EBMT). Hepa-tology 1997; 26: 260A, (abstr.)
   Google Scholar
• Pariente EA, Goudeau A, Dubois F, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci 1988; 33: 1185–91
   PubMed Web of Science ®Google Scholar
• Chen PM, Fan S, Hsieh RK, et al. Liver disease in patients with liver dysfunction prior to bone marrow transplantation. Bone Marrow Transplant 1992; 9: 415–9
   PubMed Web of Science ®Google Scholar
• Ilan Y, Nagler A, Adler R, et al. Adoptive transfer of immunity to hepatitis B virus after T-cell depleted allogeneic bone marrow transplantation. Hepatology 1993; 18: 246–52
   PubMed Web of Science ®Google Scholar
• McIvor C, Morton J, Bryant A, Cooksley WG, Durrant S, Walker N. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann Intern Med 1994; 121: 2765
   Google Scholar
• Brugger SA, Oesterreicher C, Hofmann H, Kalhs P, Greinix HT, Muller C. Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunized donor. Lancet 1997; 349: 996–7
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Testa M, Valsecchi MG, et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood 1997; 90: 3799–3805
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Bacigalupo A, VanLint MT, et al. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 1991; 52: 315–8
   PubMed Web of Science ®Google Scholar
• Shuhart MC, Myerson D, Childs BH, et al. Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood 1994; 84: 3229–35
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Nava S, Sparano P, Testa M. Infections with hepatotropic viruses in children treated with allogeneic bone marrow transplantation. Bone Marrow Transplant 21, suppl 1998; 2, S 75–7.
   Google Scholar
• Frickhofen N, Wiesneth M, Fukawa H, et al. Hepatitis C virus infection is a risk factor for liver failure from venooc-clusive disease after bone marrow transplantation. Blood 1994; 83: 1998–2004
   PubMed Web of Science ®Google Scholar
• Strasser SI, Spurgeon CL, Kim S, et al. Hepatitis C virus infection and bone marrow transplantation: a prospective study with 10 year follow-up. Hepatology. 1998, (abstr.) in press.
   Google Scholar
• Ljungman P, Hagglund H, Lonnqvist B, Sonnerborg A, Ringden O. Hepatitis C virus as a risk factor for the develop ment of veno-occlusive diseaseoetter). Blood 1994; 84: 1349
   PubMed Web of Science ®Google Scholar
• Norol F, Roche B, Saint-Marc Girardin MF, et al. Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 1994; 57: 393
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Bacigalupo A, VanLint MT, et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 407–11
   PubMed Web of Science ®Google Scholar
• Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM. Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 1991; 8: 417–20
   PubMed Web of Science ®Google Scholar
• Kanamori H, Fukawa H, Maruta A, et al. case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation. Am J Med Sci 1992; 303: 109–11
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Alberti A, Bandini G, et al. Allogeneic bone marrow transplantation from HBsAg positive donors: a mul-ticenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 1995; 86: 323640
   Google Scholar
• Martin BA, Rowe JM, Kouides PA, DiPersio JF. Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone Marrow Transplant 1995; 15: 145–8
   PubMed Web of Science ®Google Scholar
• HBeAg-negative in a previously thalassemic patient during immunosuppressive therapy for chronic GVHD. Bone Marrow Transplant 1998; 22: 919–21
   PubMed Web of Science ®Google Scholar
• Ljungman P, Johansson N, Galumann H, et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995; 86: 1614–9
   PubMed Web of Science ®Google Scholar
• Strasser SI, Spurgeon CL, Sullivan KM, McDonald GB. Cirrhosis in long-term survivors of marrow transplantation: prevalence and risk factors. Gastroenterology 1997; 112: A1391, (abstr.)
   Google Scholar